Get the Stockscreener App
0.8754
8.81%
-0.0846
Outset Medical Inc stock is traded at $0.8754, with a volume of 696.64K.
It is down -8.81% in the last 24 hours and up +8.49% over the past month.
Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.
See More
Previous Close:
$0.96
Open:
$0.96
24h Volume:
696.64K
Relative Volume:
0.67
Market Cap:
$47.01M
Revenue:
$114.73M
Net Income/Loss:
$-140.94M
P/E Ratio:
-0.3172
EPS:
-2.76
Net Cash Flow:
$-126.18M
1W Performance:
-2.63%
1M Performance:
+8.49%
6M Performance:
+26.87%
1Y Performance:
-72.73%
1-Day Range:
$0.85
$0.97
1-Week Range:
$0.8218
$1.08
52-Week Range:
$0.435
$5.22
Outset Medical Inc Stock (OM) Company Profile
Name
Outset Medical Inc
Sector
Industry
Phone
669-231-8200
Address
3052 ORCHARD DRIVE, SAN JOSE
Compare OM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OM
Outset Medical Inc
|
0.8754 | 47.01M | 114.73M | -140.94M | -126.18M | -2.76 |
|
ABT
Abbott Laboratories
|
134.92 | 234.01B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.49 | 154.20B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
382.78 | 146.06B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.94 | 115.42B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.30 | 43.23B | 5.72B | 4.17B | 490.10M | 6.97 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-08-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jun-21-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Apr-08-24 | Initiated | BTIG Research | Buy |
| Apr-05-24 | Upgrade | CL King | Neutral → Buy |
| Jan-12-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Oct-13-23 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-17-23 | Initiated | CL King | Neutral |
| Nov-11-22 | Initiated | RBC Capital Mkts | Outperform |
| Jul-14-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-17-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-18-21 | Initiated | Cowen | Outperform |
| Apr-19-21 | Initiated | Wells Fargo | Overweight |
| Dec-16-20 | Initiated | Oppenheimer | Perform |
| Oct-12-20 | Initiated | Barclays | Overweight |
| Oct-12-20 | Initiated | BofA Securities | Buy |
| Oct-12-20 | Initiated | Goldman | Buy |
| Oct-12-20 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-12-20 | Initiated | SVB Leerink | Mkt Perform |
| Oct-12-20 | Initiated | Stifel | Buy |
View All
Outset Medical Inc Stock (OM) Latest News
Outset Medical projects $115M-$125M revenue in 2025 with focus on console growth and gross margin expansion - MSN
Outset Medical Q4 2024 Earnings Preview - MSN
Outset Medical Shines Amid Revenue Growth and Operational Gains - TipRanks
Leslie Trigg Sells 14,611 Shares of Outset Medical, Inc. (NASDAQ:OM) Stock - MarketBeat
Outset Medical (NASDAQ:OM) Releases Earnings Results, Misses Expectations By $0.04 EPS - MarketBeat
Outset Medical (NASDAQ:OM) Issues Earnings Results - MarketBeat
Outset Medical stock rises on Street-beating Q4, 2025 guidance - Mass Device
Outset Medical, Inc. (NASDAQ:OM) Q4 2024 Earnings Call Transcript - Insider Monkey
Outset Medical Inc (OM) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo Finance
Outset Medical earnings beat by $0.06, revenue topped estimates - Investing.com Australia
Outset Medical, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Outset Medical Exceeds Revenue Guidance in 2024 - TipRanks
Outset Medical: Profitability Path Brightens - The Motley Fool
Outset Medical: Profitability Path Brightens - Nasdaq
Earnings call transcript: Outset Medical Q4 2024 beats EPS forecast, stock gains - Investing.com
Outset Medical general counsel sells $5,530 in stock By Investing.com - Investing.com South Africa
Outset Medical, Inc. (OM) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Outset Medical Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Outset Medical's SVP Nash Marc sells shares for $3,783 - Investing.com
Outset Medical general counsel sells $5,530 in stock - Investing.com
Outset Medical Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire
Outset Medical Reports Fourth Quarter and Full Year 2024 Financial Results -February 19, 2025 at 04:04 pm EST - Marketscreener.com
Earnings To Watch: Outset Medical Inc (OM) Reports Q4 2024 Resul - GuruFocus.com
Earnings To Watch: Outset Medical Inc (OM) Reports Q4 2024 Result - Yahoo Finance
Outset Medical SVP sells $18,576 in common stock - MSN
Levi & Korsinsky Notifies Shareholders of Outset Medical, Inc.(OM) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Outset Medical CFO Ahmed Nabeel sells $27,430 in stock - MSN
Class Action Filed Against Outset Medical, Inc. (OM) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
OM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Outset Medical, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Outset Medical general counsel John Brottem sells $26,344 in stock - MSN
Outset Medical, Inc. Announces Board and Committee Changes -March 24, 2021 at 09:16 am EDT - Marketscreener.com
OM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Outset Medical, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Outset Medical plans $100M mixed shelf offering - MSN
Outset Medical Announces Resolution of Warning Letter - GlobeNewswire
Outset Medical resolves FDA warning letter - Mass Device
Outset Medical Announces Resolution Of Warning Letter -February 13, 2025 at 05:14 pm EST - Marketscreener.com
FDA clears Outset Medical of previous warning issues - Investing.com
Outset Medical Inc. (OM) Announces Resolution of Warning Letter - StreetInsider.com
FDA Clears Outset Medical: Major Regulatory Victory for Revolutionary Dialysis Tech - StockTitan
Outset Medical Inc. (OM) Files $100M Mixed Shelf - StreetInsider.com
OM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Outset Medical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Outset Medical, Inc. (OM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
BTIG cuts Outset Medical target to $3, maintains Buy rating - MSN
Outset medical stock news: OM stock poised for growth amid transformation - Markets.com
OM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Outset Medical, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Outset Medical to Report Fourth Quarter and Full-Year 2024 Financial Results on Wednesday, February 19, 2025 - The Manila Times
Outset Medical Q4 Earnings: Key Financial Updates Coming as Dialysis Tech Leader Reports - StockTitan
OM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Outset Medical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Outset Medical, Inc. (OM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
OM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Outset Medical, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Vanguard Group Inc Reduces Stake in Outset Medical Inc - GuruFocus.com
Outset Medical Inc Stock (OM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Outset Medical Inc Stock (OM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Nash Marc | SVP Operations and R&D |
Feb 18 '25 |
Sale |
0.90 |
4,204 |
3,784 |
200,764 |
| Brottem John L. | General Counsel |
Feb 18 '25 |
Sale |
0.90 |
6,145 |
5,530 |
175,043 |
| Ahmed Nabeel | Chief Financial Officer |
Feb 18 '25 |
Sale |
0.90 |
8,659 |
7,793 |
250,210 |
1.16%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):